CHASERR

gene
On this page

Summary

CHASERR (CHD2 adjacent suppressive regulatory RNA, HGNC:48626) is a long non-coding RNA gene on chromosome 15q26.1.

Predicted to be involved in several processes, including adipose tissue development; regulation of gene expression; and thymus development. Predicted to be active in chromatin and nucleus.

Source: NCBI Gene 100507217 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:48626
Approved symbolCHASERR
NameCHD2 adjacent suppressive regulatory RNA
Location15q26.1
Locus typeRNA, long non-coding
StatusApproved
Ensembl geneENSG00000272888
Ensembl biotypelncRNA
OMIM620993
Entrez100507217
RNAcentralURS000075A1CF — lncRNA, 1787 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 20 — 18 lncRNA, 2 retained_intron

ENST00000553829, ENST00000554133, ENST00000554669, ENST00000554894, ENST00000555227, ENST00000555520, ENST00000556895, ENST00000557147, ENST00000557682, ENST00000610332, ENST00000653163, ENST00000692976, ENST00000803209, ENST00000803210, ENST00000803211, ENST00000803212, ENST00000803213, ENST00000803214, ENST00000816678, ENST00000816679

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000553829 — 2 exons

ExonStartEnd
ENSE000024917549288358592883861
ENSE000025207559288273292883186

Expression profiles

Bgee: expression breadth ubiquitous, 256 present calls, max score 99.50.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 157.8072 / max 2561.5140, expressed in 1827 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
148635143.25441827
14863413.15161799
1486360.5369254
1486370.4728208
1486380.3916175

Top tissues by expression

256 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
vena cavaUBERON:000408799.50gold quality
calcaneal tendonUBERON:000370199.40gold quality
ventricular zoneUBERON:000305399.38gold quality
tracheaUBERON:000312699.38gold quality
parotid glandUBERON:000183199.35gold quality
ganglionic eminenceUBERON:000402399.30gold quality
upper arm skinUBERON:000426399.28gold quality
oviduct epitheliumUBERON:000480499.28gold quality
synovial jointUBERON:000221799.18gold quality
urethraUBERON:000005799.17gold quality
pericardiumUBERON:000240799.17gold quality
ponsUBERON:000098899.13gold quality
cartilage tissueUBERON:000241899.10gold quality
corpus callosumUBERON:000233699.09gold quality
subthalamic nucleusUBERON:000190699.04gold quality
layer of synovial tissueUBERON:000761699.00gold quality
lateral globus pallidusUBERON:000247698.96gold quality
cardia of stomachUBERON:000116298.95gold quality
renal medullaUBERON:000036298.94gold quality
penisUBERON:000098998.92gold quality
medulla oblongataUBERON:000189698.91gold quality
substantia nigra pars reticulataUBERON:000196698.91gold quality
inferior vagus X ganglionUBERON:000536398.90gold quality
saphenous veinUBERON:000731898.90gold quality
olfactory segment of nasal mucosaUBERON:000538698.88gold quality
tendonUBERON:000004398.86gold quality
trigeminal ganglionUBERON:000167598.79gold quality
thymusUBERON:000237098.78gold quality
superior surface of tongueUBERON:000737198.75gold quality
ventral tegmental areaUBERON:000269198.72gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 2)

  • Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-kappaB/YY1 axis. (PMID:33040438)
  • LINC01578 affects the radiation resistance of lung cancer cells through regulating microRNA-216b-5p/TBL1XR1 axis. (PMID:35475502)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.